Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-9-7
pubmed:abstractText
Our primary objective was to evaluate the effectiveness and tolerability of intramuscular ziprasidone for impulsivity and agitation in psychiatrically hospitalized children and adolescents. Our secondary objective was to examine demographic and clinical factors associated with treatment response.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1044-5463
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
503-9
pubmed:meshHeading
pubmed-meshheading:17822344-Adolescent, pubmed-meshheading:17822344-Adult, pubmed-meshheading:17822344-Age Factors, pubmed-meshheading:17822344-Antipsychotic Agents, pubmed-meshheading:17822344-Child, pubmed-meshheading:17822344-Child, Preschool, pubmed-meshheading:17822344-Electrocardiography, pubmed-meshheading:17822344-Female, pubmed-meshheading:17822344-Hospitals, Pediatric, pubmed-meshheading:17822344-Humans, pubmed-meshheading:17822344-Injections, Intramuscular, pubmed-meshheading:17822344-Male, pubmed-meshheading:17822344-Mental Disorders, pubmed-meshheading:17822344-Piperazines, pubmed-meshheading:17822344-Psychiatric Department, Hospital, pubmed-meshheading:17822344-Psychiatric Status Rating Scales, pubmed-meshheading:17822344-Psychomotor Agitation, pubmed-meshheading:17822344-Regression Analysis, pubmed-meshheading:17822344-Retrospective Studies, pubmed-meshheading:17822344-Sex Factors, pubmed-meshheading:17822344-Sleep Stages, pubmed-meshheading:17822344-Thiazoles, pubmed-meshheading:17822344-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed.
pubmed:affiliation
Children's Hospital Medical Center, Division of Child and Adolescent Psychiatry, Cincinnati, Ohio 45229-3039, USA. drew.barzman@fuse.net
pubmed:publicationType
Journal Article